IgG1/IgG2 antibody dichotomy in sera of vaccinated or naturally infected dogs with visceral leishmaniosis (Q60227749)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12744895%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

title

IgG1/IgG2 antibody dichotomy in sera of vaccinated or naturally infected dogs with visceral leishmaniosis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12744895%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

1 reference

Gulnara Patrícia Borja-Cabrera

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12744895%20AND%20SRC:MED&resulttype=core&format=json

Clarisa Beatriz Palatnik-de-Sousa

3 November 2019

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12744895%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

author name string

Carolina de Oliveira Mendes

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12744895%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Edilma Paraguai de Souza

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12744895%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Leopoldina Maria Melo Batista

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12744895%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Miriam Aparecida dos Santos

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12744895%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Luciana Ellner Parra

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12744895%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Ingrid Menz

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12744895%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Marcos Palatnik

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12744895%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

language of work or name

English

0 references

publication date

1 June 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12744895%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12744895%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

volume

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12744895%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

issue

19-20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12744895%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

page(s)

2589-2597

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12744895%20AND%20SRC:MED&resulttype=core&format=json

Impact of canine control on the epidemiology of canine and human visceral leishmaniasis in Brazil

3 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900046-X

7 January 2021

Vaccination of Swiss Albino mice against experimental visceral leishmaniasis with the FML antigen of Leishmania donovani.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900046-X

7 January 2021

Saponins, IL12 and BCG adjuvant in the FML-vaccine formulation against murine visceral leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900046-X

7 January 2021

Long lasting protection against canine kala-azar using the FML-QuilA saponin vaccine in an endemic area of Brazil (S�o Gon�alo do Amarante, RN)

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900046-X

7 January 2021

The fucose-mannose ligand-ELISA in the diagnosis and prognosis of canine visceral leishmaniasis in Brazil

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900046-X

7 January 2021

The significance of blood levels of IgM, IgA, IgG and IgG subclasses in Sudanese visceral leishmaniasis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900046-X

7 January 2021

Distribution of IgG subclasses in antimonial unresponsive Indian kala-azar patients

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900046-X

7 January 2021

Altered immunomodulating and toxicological properties of degraded Quillaja saponaria Molina saponins.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900046-X

7 January 2021

Specific IgG1 and IgG2 antibody responses of dogs to Leishmania infantum and other parasites

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900046-X

7 January 2021

Leishmania donovani: titration of antibodies to the fucose-mannose ligand as an aid in diagnosis and prognosis of visceral leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900046-X

7 January 2021

A cross-sectional serodiagnostic survey of canine leishmaniasis due to Leishmania chagasi.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900046-X

7 January 2021

Studies on the control of visceral leishmaniasis: validation of the Falcon assay screening test--enzyme-linked immunosorbent assay (FAST-ELISA) for field diagnosis of canine visceral leishmaniasis.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900046-X

7 January 2021

Effect of eliminating seropositive canines on the transmission of visceral leishmaniasis in Brazil

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900046-X

7 January 2021

Demonstration of Leishmania specific cell mediated and humoral immunity in asymptomatic dogs

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900046-X

7 January 2021

Cellular and humoral immune responses in dogs experimentally and naturally infected with Leishmania infantum

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900046-X

7 January 2021

Leishmania infantum-specific IgG, IgG1 and IgG2 antibody responses in healthy and ill dogs from endemic areas. Evolution in the course of infection and after treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900046-X

7 January 2021

Antigen-specific immunosuppression in visceral leishmaniasis is cell mediated

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900046-X

7 January 2021

The Ibizian hound presents a predominantly cellular immune response against natural Leishmania infection

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900046-X

7 January 2021

Immunobiological studies on experimental visceral leishmaniasis. II. Adherent cell-mediated down-regulation of delayed-type hypersensitivity response and up-regulation of B cell activation

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900046-X

7 January 2021

Canine leishmaniasis transmission: higher infectivity amongst naturally infected dogs to sand flies is associated with lower proportions of T helper cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900046-X

7 January 2021

Specific IgG1 and IgG2 antibody and lymphocyte subset levels in naturally Leishmania infantum-infected treated and untreated dogs

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900046-X

7 January 2021

The immune response and PBMC subsets in canine visceral leishmaniasis before, and after, chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900046-X

7 January 2021

Analysis of the humoral immune response against total and recombinant antigens of Leishmania infantum: correlation with disease progression in canine experimental leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900046-X

7 January 2021

Nucleoside hydrolase from Leishmania (L.) donovani is an antigen diagnostic for visceral leishmaniasis.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900046-X

7 January 2021

Vaccination of Balb/c mice against experimental visceral leishmaniasis with the GP36 glycoprotein antigen of Leishmania donovani

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900046-X

7 January 2021

The FML (Fucose Mannose Ligand) of Leishmania donovani. a new tool in diagnosis, prognosis, transfusional control and vaccination against human kala-azar

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900046-X

7 January 2021

Characterization of canine humoral immune responses to outer surface protein subunit vaccines and to natural infection by Lyme disease spirochetes

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900046-X

7 January 2021

Salmonella typhimurium as a basis for a live oral Echinococcus granulosus vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900046-X

7 January 2021

10.1016/S0264-410X(03)00046-X

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12744895%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

1 reference